1. Home
  2. KROS vs RDVT Comparison

KROS vs RDVT Comparison

Compare KROS & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • RDVT
  • Stock Information
  • Founded
  • KROS 2015
  • RDVT 2017
  • Country
  • KROS United States
  • RDVT United States
  • Employees
  • KROS N/A
  • RDVT N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • RDVT Computer Software: Prepackaged Software
  • Sector
  • KROS Health Care
  • RDVT Technology
  • Exchange
  • KROS Nasdaq
  • RDVT Nasdaq
  • Market Cap
  • KROS 460.6M
  • RDVT 486.6M
  • IPO Year
  • KROS 2020
  • RDVT N/A
  • Fundamental
  • Price
  • KROS $11.00
  • RDVT $39.34
  • Analyst Decision
  • KROS Buy
  • RDVT Strong Buy
  • Analyst Count
  • KROS 11
  • RDVT 1
  • Target Price
  • KROS $45.33
  • RDVT $25.00
  • AVG Volume (30 Days)
  • KROS 2.1M
  • RDVT 61.1K
  • Earning Date
  • KROS 02-26-2025
  • RDVT 03-06-2025
  • Dividend Yield
  • KROS N/A
  • RDVT 0.78%
  • EPS Growth
  • KROS N/A
  • RDVT N/A
  • EPS
  • KROS N/A
  • RDVT 0.36
  • Revenue
  • KROS $651,000.00
  • RDVT $70,685,000.00
  • Revenue This Year
  • KROS $303.27
  • RDVT $24.88
  • Revenue Next Year
  • KROS N/A
  • RDVT $14.52
  • P/E Ratio
  • KROS N/A
  • RDVT $107.25
  • Revenue Growth
  • KROS 8037.50
  • RDVT 21.43
  • 52 Week Low
  • KROS $9.78
  • RDVT $16.56
  • 52 Week High
  • KROS $73.00
  • RDVT $39.88
  • Technical
  • Relative Strength Index (RSI)
  • KROS 24.79
  • RDVT 69.22
  • Support Level
  • KROS $11.04
  • RDVT $35.52
  • Resistance Level
  • KROS $11.99
  • RDVT $36.54
  • Average True Range (ATR)
  • KROS 0.60
  • RDVT 1.13
  • MACD
  • KROS 1.20
  • RDVT 0.40
  • Stochastic Oscillator
  • KROS 43.99
  • RDVT 96.96

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About RDVT Red Violet Inc.

Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses, and assets.

Share on Social Networks: